Inputs
Five public sources, each a link in the forecast JSON.
- 01Registry record
phase, enrolment, sponsor class, the endpoint's class
- 02Open Targets
the drug target's association with Alzheimer's
- 03Sponsor record
its posted readouts before tonight, and how many hit
- 04Class base rate
the pipeline reviews, PMIDs 25024750 and 42095064
- 05PubMed
papers on the drug and Alzheimer's in 24 months
Class priors
Chance that one named endpoint clears alpha 0.05, before any factor.
| Endpoint | P2 | P2/3 | P3 |
|---|---|---|---|
| cognitive-functional | 18% | 16% | 12% |
| neuropsychiatric | 32% | 30% | 30% |
| biomarker | 50% | 50% | 50% |
| other | 22% | 20% | 20% |
0.4% of Alzheimer's drugs reached approval over 2002-2012 (Cummings 2014). One endpoint is a lower bar than approval, so the priors sit above it.
The bond
2,000 $PLCB per open market, held by the contract.
- ≤.25Brier at or under 0.25
Returned in full by releaseBonds.
- >.25Above 0.25
Half is sent to 0x…dEaD, half returned.
The bond is posted from the first night after $PLCB is set on the contract.
The model placebo-1
log-odds = logit(prior[endpoint][phase])
+ 1.10 × (G − 0.30)
+ 0.30 × clamp(ln(n / 300), −1.5, 1.5)
+ 0.20 × industry
+ 1.20 × ((hits + 1) / (readouts + 4) − 0.25)
+ 0.12 × ln(1 + papers / 20)
p = clamp(1 / (1 + e^−log-odds), 0.03, 0.92), rounded to 0.01| Term | Definition |
|---|---|
| Class prior | logit(prior[endpoint][phase]) |
| Genetic support | 1.10 × (G − 0.30), G = highest Open Targets association of the drug's targets with Alzheimer's |
| Size | 0.30 × clamp(ln(n / 300), −1.5, 1.5), n = enrolment |
| Sponsor class | 0.20 if the lead sponsor is industry |
| Sponsor record | 1.20 × ((hits + 1) / (readouts + 4) − 0.25), the sponsor's posted readouts before tonight |
| Literature | 0.12 × ln(1 + papers / 20), PubMed papers on the drug and Alzheimer's in the 24 months before |
No language model is called. The three sentences of reasoning are written from these numbers by a fixed template, so the same inputs always give the same JSON and the same sha256.
On the replay
All 81 →Mean forecast per decile against the share that hit. The dashed line is perfect calibration.
Brier 0.1895 on 81 readouts, against 0.1859 for always saying the base rate of 25%. The model is close to the base rate and not yet better than it; the live record decides whether its factors add anything.
Tonight
2026-10-13| Market | G | n | record | p |
|---|---|---|---|---|
| XanaMIA | 0.10 | 247 | 0/0 | 15% |
| Polaris-AD | 0.29 | 1,535 | 0/0 | 21% |
| ADEPT-2 | 0.43 | 500 | 0/0 | 43% |
| ACP-204 | 0.42 | 1,074 | 1/1 | 53% |
| Masupirdine | 0.42 | 375 | 0/1 | 38% |
| TRONTIER 1 | 0.87 | 1,101 | 0/4 | 31% |
| TRONTIER 2 | 0.87 | 1,060 | 0/4 | 30% |

